[Therapy of malignant tumors through the internist].
D001761:Bleomycin / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D008558:Melphalan / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D012516:Osteosarcoma / Q000188:drug therapy*; D010954:Plasmacytoma / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D012512:Sarcoma, Ewing / Q000188:drug therapy*; D014750:Vincristine / Q000627:therapeutic use
D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008558:Melphalan; D011241:Prednisone; D008727:Methotrexate
Internistische Therapie von malignen Knochentumoren und Metastasen.